Literature DB >> 9112294

Distribution of hepatitis C virus genotypes in Slovenia.

K Seme1, M Poljak, G Lesnicar, V Brinovec, S Stepec, S Koren.   

Abstract

To determine the prevalence of HCV genotypes in Slovenia, 203 subjects infected with hepatitis C virus (HCV) were studied using the Inno-Lipa HCV II assay (Innogenetics, Belgium). Of 21 patients infected by blood transfusion 19% had HCV subtype 1a, 81% had subtype 1b, and none of them was infected with genotype 3. In chronic hepatitis C patients infected by unknown cause subtype 1b was the most prevalent (54.4%), followed by subtype 1a (24.6%), genotype 3 (15.8%) and genotype 2 (5.2%). Genotype 3 (45.9%) and subtype 1a (43.2%) predominated among 74 intravenous drug users. In 37 haemodialysis patients genotypes 1 and 2 were almost equally frequent (40.5% and 37.8%, respectively), followed by genotype 3 (21.6%). Significant differences in HCV genotype distribution among distinct epidemiological groups observed in Slovenia indicate a close relationship between certain HCV genotypes and particular routes of viral transmission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112294     DOI: 10.3109/00365549709008660

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Authors:  Matthias Schröter; Bernhard Zöllner; Peter Schäfer; Andreas Reimer; Matthias Müller; Rainer Laufs; Heinz-Hubert Feucht
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Mistyping of two Slovenian hepatitis C virus subtype 2c isolates as subtype 2b by two 5' noncoding region genotyping methods.

Authors:  K Seme; M Poljak; S Koren; P Dovc
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.